The Army Medical University, formerly the Third Military Medical University, is a Chinese medical education institution affiliated to the People's Liberation Army, located in Chongqing. The Army Medical University was founded in 1954 by the merger of former Sixth and Seventh Medical Universities.

During the past decade, Daping Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Daping Hospital" #1 sponsor was "Third Military Medical University" with 13 trials, followed by "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University" with 5 trials sponsored, "BeiGene" with 3 trials sponsored, "Peking Union Medical College Hospital" with 3 trials sponsored and "Chinese Academy of Medical Sciences, Fuwai Hospital" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Daping Hospital" #1 collaborator was "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University" with 1 trials as a collaborator and "Shandong Weigao Panion Pharmaceutical Co. Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Daping Hospital" are "Non-small Cell Lung Cancer" (3 trials), "Stroke" (3 trials), "Rectal Cancer" (2 trials), "Rectal Neoplasms" (2 trials) and "Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Daping Hospital" in a lesser frequency.

Most popular intervention types in "Daping Hospital" are "Drug" (28 trials), "Procedure" (9 trials), "Other" (6 trials), "Device" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apatinib" (2 trials), "Docetaxel" (2 trials), "Tislelizumab" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Daping Hospital" are 44 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 16 active trials in "Daping Hospital". 2 are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Daping Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Daping Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 21 trials that are defined as “Not Applicable".